RIPK3 and breast neoplasm: Interestingly, while consistent with previous findings, we found that RIPK3 expression is decreased in the early stages of mouse MMVT-PyMT breast tumors, a significant increase of RIPK3 expression was detected in late stage tumors that bear tumor necrosis [41].